Manufacturer:
Boehringer Ingelheim
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
Approved Indication:
treatment of adult patients with idiopathic pulmonary fibrosis
Conditions:
- Idiopathic Pulmonary Fibrosis